Literature DB >> 17228870

Dissection of the recognition properties of p38 MAP kinase. Determination of the binding mode of a new pyridinyl-heterocycle inhibitor family.

Robert Soliva1, Josep Lluis Gelpí, Carmen Almansa, Marina Virgili, Modesto Orozco.   

Abstract

The main recognition characteristics of the ATP binding site of p38 mitogen activated protein kinase alpha (p38alpha MAPK) have been explored by a combination of modeling and bioinformatics techniques, making special emphasis in the characteristics of the site that justifies binding specificity with respect to other MAP kinases. Particularly, we have analyzed the binding mode of a new family of p38 MAPK inhibitors based on the pyridinyl-heterocycle core. This family of compounds has a marked pseudosymmetry and can exist in different tautomeric forms, which makes the determination of the binding mode especially challenging. A combination of homology modeling, quantum mechanics, classical docking, and molecular dynamics calculations allowed us to determine the main characteristics defining the binding mode of this new scaffold in the ATP binding site of p38alpha. A set of free energy calculations allowed us to verify the binding mode proposed, giving an overall excellent agreement with the experimental values. Finally, the binding mode of this new family of compounds was compared to that of other members of the pyridinyl and pyrimidinyl heterocycle class.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17228870     DOI: 10.1021/jm061073h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Discrete molecular dynamics distinguishes nativelike binding poses from decoys in difficult targets.

Authors:  Elizabeth A Proctor; Shuangye Yin; Alexander Tropsha; Nikolay V Dokholyan
Journal:  Biophys J       Date:  2012-01-03       Impact factor: 4.033

2.  Rapid flexible docking using a stochastic rotamer library of ligands.

Authors:  Feng Ding; Shuangye Yin; Nikolay V Dokholyan
Journal:  J Chem Inf Model       Date:  2010-09-27       Impact factor: 4.956

3.  A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha.

Authors:  K Mihara; C Almansa; R L Smeets; E E M G Loomans; J Dulos; P M F Vink; M Rooseboom; H Kreutzer; F Cavalcanti; A M Boots; R L Nelissen
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

4.  Target flexibility: an emerging consideration in drug discovery and design.

Authors:  Pietro Cozzini; Glen E Kellogg; Francesca Spyrakis; Donald J Abraham; Gabriele Costantino; Andrew Emerson; Francesca Fanelli; Holger Gohlke; Leslie A Kuhn; Garrett M Morris; Modesto Orozco; Thelma A Pertinhez; Menico Rizzi; Christoph A Sotriffer
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

5.  Consistent improvement of cross-docking results using binding site ensembles generated with elastic network normal modes.

Authors:  Manuel Rueda; Giovanni Bottegoni; Ruben Abagyan
Journal:  J Chem Inf Model       Date:  2009-03       Impact factor: 4.956

Review 6.  Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.

Authors:  Mark C Bagley; Terence Davis; Paola G S Murziani; Caroline S Widdowson; David Kipling
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.